Pancreatic cancer is the third leading cause of cancer-related deaths, trailing behind lung cancer and colorectal cancer, a ...

Discover GRAIL’s MCED screening tests, Illumina’s divestiture impact, and an $8B valuation base with TAM upside tied to FDA ...

Shares of Grail have quintupled this year to nearly $90, as investors waited for news about the Pathfinder 2 study of its cancer-detecting blood test. Management hinted this summer the numbers were ...

Researchers hope to improve survival rates through early detection with a blood test that can detect over 50 types of cancer.

Early-stage cancer detection startup Grail, which has investors including Amazon CEO Jeff Bezos, has filed to go public, according to a Sept. 9 CNBC report. 1. DNA-sequencing machine developer ...

Age is one of the most significant risk factors for cancer and numerous Medicare beneficiaries face an unmet need for early cancer detection.

A three-year clinical trial seeks to find out if a simple blood test can detect cancer in senior citizens. The post Can a ...

CHICAGO -- Hundreds of people using the test company Grail were wrongly told they might have cancer, the company said in a statement Monday. Grail said a software glitch related to their telemedicine ...

MENLO PARK, Calif., Oct. 17, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that positive ...

What these buzzy new tests can and can't tell you.

Galleri Accurately Predicted the Location of the Cancer in Almost All Cases Initially Considered as False Positives, Reinforcing the Value of Galleri's CSO Capability MENLO PARK, Calif. and OXFORD, ...